Waters Feb 9, 2026 BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation - Becton Dickinson
Endpoints News Feb 9, 2026 #ACTRIMS26: Roche’s MS drug fenebrutinib beats Ocrevus, cutting risk of disability progression by 12%
PLoS Biology Feb 9, 2026 CUL5 E3 ubiquitin ligase regulates the evasion of bladder cancer cells to CD8<sup>+</sup> T cell-mediated killing by inhibiting autophagy
Waters Feb 9, 2026 BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation - Yahoo Finance
Roche Media Feb 9, 2026 Roche’s fenebrutinib demonstrates decade-first benefit in multiple sclerosis - European Pharmaceutical Review
Endpoints News Feb 9, 2026 Novo Nordisk sues Hims over Wegovy patent infringement, considers seeking 'hundreds of millions' in damages